Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Active drug efflux transporters of the ATP binding cassette (ABC)-containing family of
proteins have a major impact on the pharmacological behavior of most of the drugs in use …
proteins have a major impact on the pharmacological behavior of most of the drugs in use …
Multidrug resistance (MDR) in cancer: mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of …
R Krishna, LD Mayer - European journal of pharmaceutical sciences, 2000 - Elsevier
In recent years, there has been an increased understanding of P-glycoprotein (P-GP)-
mediated pharmacokinetic interactions. In addition, its role in modifying the bioavailability of …
mediated pharmacokinetic interactions. In addition, its role in modifying the bioavailability of …
P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.
AH Schinkel, E Wagenaar, CA Mol… - The Journal of …, 1996 - Am Soc Clin Investig
The mouse mdr1a (also called mdr3) P-GP is abundant in the blood-brain barrier, and its
absence in mdr1a (-/-) mice leads to highly increased levels of the drugs ivermectin …
absence in mdr1a (-/-) mice leads to highly increased levels of the drugs ivermectin …
Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.
AH Schinkel, E Wagenaar… - The Journal of …, 1995 - Am Soc Clin Investig
We have previously shown that absence of the mouse mdr1a (also called mdr3) P-
glycoprotein in mdr1a (-/-)" knockout" mice has a profound effect on the tissue distribution …
glycoprotein in mdr1a (-/-)" knockout" mice has a profound effect on the tissue distribution …
ABCB1 and ABCG2 regulation at the blood-brain barrier: potential new targets to improve brain drug delivery
The drug efflux transporters ABCB1 and ABCG2 at the blood-brain barrier limit the delivery
of drugs into the brain. Strategies to overcome ABCB1/ABCG2 have been largely …
of drugs into the brain. Strategies to overcome ABCB1/ABCG2 have been largely …
ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal
CH Choi - Cancer cell international, 2005 - Springer
One of the major problems related with anticancer chemotherapy is resistance against
anticancer drugs. The ATP-binding cassette (ABC) transporters are a family of transporter …
anticancer drugs. The ATP-binding cassette (ABC) transporters are a family of transporter …
The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates.
I Leier, G Jedlitschky, U Buchholz, SPC Cole… - Journal of Biological …, 1994 - Elsevier
The multidrug resistance-associated protein (MRP) is the product of an ATP-binding
cassette transporter gene overexpressed in some tumor cells resistant to antineoplastic …
cassette transporter gene overexpressed in some tumor cells resistant to antineoplastic …
Clinical perspective of FDA approved drugs with P-glycoprotein inhibition activities for potential cancer therapeutics
JI Lai, YJ Tseng, MH Chen, CYF Huang… - Frontiers in …, 2020 - frontiersin.org
P-glycoprotein (also known as multidrug resistance protein 1 (MDR1) or ATP-binding
cassette sub-family B member 1 (ABCB1) plays a crucial role in determining response …
cassette sub-family B member 1 (ABCB1) plays a crucial role in determining response …
[HTML][HTML] Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance
The membrane proteins mediating the ATP-dependent transport of lipophilic substances
conjugated to glutathione, glucuronate, or sulfate have been identified as members of the …
conjugated to glutathione, glucuronate, or sulfate have been identified as members of the …
[HTML][HTML] P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
HM Abdallah, AM Al-Abd, RS El-Dine… - Journal of advanced …, 2015 - Elsevier
Resistance of solid tumors to treatment is significantly attributed to pharmacokinetic reasons
at both cellular and multi-cellular levels. Anticancer agent must be bio-available at the site of …
at both cellular and multi-cellular levels. Anticancer agent must be bio-available at the site of …